View in EDS HTML Full Text PDF Full Text

A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.

Saved in:
Bibliographic Details
Title: A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.
Authors: Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yamanaka T; Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan., Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Yamamoto N; Department of Breast Surgery, Chiba Cancer Center Hospital, Chiba, Japan., Chung CF; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Chang DY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim GM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Iwasa T; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan., Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Watanabe K; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Tanabe Y; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Kang SY; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea., Yasojima H; Departments of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Aogi K; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Tokunaga E; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Sim SH; Center for Breast Cancer, National Cancer Center, Goyang-Si, Republic of Korea., Yap YS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Matsumoto K; Hyogo Cancer Center Division of Medical Oncology, Akashi, Japan., Tseng LM; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan., Umeyama Y; Pfizer R&D Japan, Tokyo, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Hata T; International Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Kuchiba A; Biostatistics Section, Clinical Research Support Office National Cancer Center Hospital/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan., Shibata T; Biostatistics Section, Clinical Research Support Office National Cancer Center Hospital/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan., Nakamura K; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Tamura K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp.
Source: NPJ breast cancer [NPJ Breast Cancer] 2024 Aug 22; Vol. 10 (1), pp. 76. Date of Electronic Publication: 2024 Aug 22.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39174547
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Noguchi+E%22">Noguchi E</searchLink>; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamanaka+T%22">Yamanaka T</searchLink>; Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Mukai+H%22">Mukai H</searchLink>; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+N%22">Yamamoto N</searchLink>; Department of Breast Surgery, Chiba Cancer Center Hospital, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Chung+CF%22">Chung CF</searchLink>; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lu+YS%22">Lu YS</searchLink>; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+DY%22">Chang DY</searchLink>; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Sohn+J%22">Sohn J</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+GM%22">Kim GM</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Iwasa+T%22">Iwasa T</searchLink>; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Iwata+H%22">Iwata H</searchLink>; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+K%22">Watanabe K</searchLink>; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Jung+KH%22">Jung KH</searchLink>; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Tanabe+Y%22">Tanabe Y</searchLink>; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kang+SY%22">Kang SY</searchLink>; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yasojima+H%22">Yasojima H</searchLink>; Departments of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Aogi+K%22">Aogi K</searchLink>; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Tokunaga+E%22">Tokunaga E</searchLink>; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Sim+SH%22">Sim SH</searchLink>; Center for Breast Cancer, National Cancer Center, Goyang-Si, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yap+YS%22">Yap YS</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Matsumoto+K%22">Matsumoto K</searchLink>; Hyogo Cancer Center Division of Medical Oncology, Akashi, Japan.<br /><searchLink fieldCode="AU" term="%22Tseng+LM%22">Tseng LM</searchLink>; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Umeyama+Y%22">Umeyama Y</searchLink>; Pfizer R&D Japan, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sudo+K%22">Sudo K</searchLink>; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kojima+Y%22">Kojima Y</searchLink>; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hata+T%22">Hata T</searchLink>; International Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kuchiba+A%22">Kuchiba A</searchLink>; Biostatistics Section, Clinical Research Support Office National Cancer Center Hospital/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shibata+T%22">Shibata T</searchLink>; Biostatistics Section, Clinical Research Support Office National Cancer Center Hospital/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+K%22">Nakamura K</searchLink>; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fujiwara+Y%22">Fujiwara Y</searchLink>; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tamura+K%22">Tamura K</searchLink>; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yonemori+K%22">Yonemori K</searchLink>; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2024 Aug 22; Vol. 10 (1), pp. 76. <i>Date of Electronic Publication: </i>2024 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39174547
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-024-00684-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 76
    Titles:
      – TitleFull: A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Noguchi E
      – PersonEntity:
          Name:
            NameFull: Yamanaka T
      – PersonEntity:
          Name:
            NameFull: Mukai H
      – PersonEntity:
          Name:
            NameFull: Yamamoto N
      – PersonEntity:
          Name:
            NameFull: Chung CF
      – PersonEntity:
          Name:
            NameFull: Lu YS
      – PersonEntity:
          Name:
            NameFull: Chang DY
      – PersonEntity:
          Name:
            NameFull: Sohn J
      – PersonEntity:
          Name:
            NameFull: Kim GM
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Lee SC
      – PersonEntity:
          Name:
            NameFull: Iwasa T
      – PersonEntity:
          Name:
            NameFull: Iwata H
      – PersonEntity:
          Name:
            NameFull: Watanabe K
      – PersonEntity:
          Name:
            NameFull: Jung KH
      – PersonEntity:
          Name:
            NameFull: Tanabe Y
      – PersonEntity:
          Name:
            NameFull: Kang SY
      – PersonEntity:
          Name:
            NameFull: Yasojima H
      – PersonEntity:
          Name:
            NameFull: Aogi K
      – PersonEntity:
          Name:
            NameFull: Tokunaga E
      – PersonEntity:
          Name:
            NameFull: Sim SH
      – PersonEntity:
          Name:
            NameFull: Yap YS
      – PersonEntity:
          Name:
            NameFull: Matsumoto K
      – PersonEntity:
          Name:
            NameFull: Tseng LM
      – PersonEntity:
          Name:
            NameFull: Umeyama Y
      – PersonEntity:
          Name:
            NameFull: Sudo K
      – PersonEntity:
          Name:
            NameFull: Kojima Y
      – PersonEntity:
          Name:
            NameFull: Hata T
      – PersonEntity:
          Name:
            NameFull: Kuchiba A
      – PersonEntity:
          Name:
            NameFull: Shibata T
      – PersonEntity:
          Name:
            NameFull: Nakamura K
      – PersonEntity:
          Name:
            NameFull: Fujiwara Y
      – PersonEntity:
          Name:
            NameFull: Tamura K
      – PersonEntity:
          Name:
            NameFull: Yonemori K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 08
              Text: 2024 Aug 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1